goBalto, Inc. said it has announced a two-year partnership with the Society for Clinical Research Sites (SCRS), the globe trade organization fully dedicated to representing the interests of clinical research sites.
Under the agreement, goBalto will participate as a Global Impact Partner (GIP), a relationship designed to facilitate critical dialogue between industry stakeholders and clinical research sites.
As a GIP, goBalto will participate on the SCRS Global Impact board at an executive level, and work in tandem with SCRS´ Leadership Council in the development and execution of strategic initiatives for SCRS.
SCRS is a global trade organization founded in 2012 which represents over 2,600 research sites, collectively conducting over 100,000 clinical studies, among 48,000 research professionals in 42 countries.
goBalto develops next-generation solutions that simplify and accelerate clinical study startup in the pharmaceutical, biotechnology, and medical device industries.